Extract notice to the Minister
Xolair
Common name / Subject : omalizumab
Name of the manufacturer : Novartis
Form : Pd. Inj.
Dosage : 150 mg
Name of the manufacturer : Novartis
Form : Pd. Inj.
Dosage : 150 mg
Indication : Urticaire chronique idiopathique
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments - Médicament d’exception
Evaluation published on June 01, 2017